OI
ZBH icon

Oakbrook Investments’s Zimmer Biomet ZBH Stock Holding History

Oakbrook Investments’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,116
Closed -$1.76M – 532
2019
Q4 		$1.76M Sell
12,116
-4,583
-27% -$633K 0.36% 45
2019
Q3 		$2.23M Sell
16,699
-2,575
-13% -$333K 0.14% 100
2019
Q2 		$2.2M Sell
19,274
-26
-0.1% -$3.04K 0.13% 109
2019
Q1 		$2.39M Hold
19,300
– – 0.15% 114
2018
Q4 		$1.94M Sell
19,300
-1,782
-8% -$200K 0.13% 119
2018
Q3 		$2.69M Buy
21,082
+5,047
+31% +$600K 0.15% 113
2018
Q2 		$1.74M Buy
16,035
+204
+1% +$22.2K 0.11% 137
2018
Q1 		$1.68M Buy
15,831
+999
+7% +$116K 0.1% 151
2017
Q4 		$1.74M Sell
14,832
-180
-1% -$20.4K 0.11% 138
2017
Q3 		$1.71M Sell
15,012
-1,473
-9% -$170K 0.11% 151
2017
Q2 		$2.06M Buy
16,485
+7,962
+93% +$944K 0.14% 130
2017
Q1 		$1.01M Buy
+8,523
New +$966K 0.07% 224
2016
Q2 		– Sell
-10,171
Closed -$1.05M – 595
2016
Q1 		$1.05M Sell
10,171
-9,579
-49% -$927K 0.07% 231
2015
Q4 		$1.97M Sell
19,750
-2,498
-11% -$244K 0.13% 143
2015
Q3 		$2.03M Buy
22,248
+11,175
+101% +$1.12M 0.13% 147
2015
Q2 		$1.17M Sell
11,073
-14,960
-57% -$1.66M 0.07% 243
2015
Q1 		$2.97M Sell
26,033
-464
-2% -$52.9K 0.16% 141
2014
Q4 		$2.92M Sell
26,497
-1,390
-5% -$147K 0.16% 134
2014
Q3 		$2.72M Sell
27,887
-29,046
-51% -$2.86M 0.15% 145
2014
Q2 		$5.74M Buy
56,933
+4,248
+8% +$414K 0.17% 142
2014
Q1 		$4.84M Buy
52,685
+19,004
+56% +$1.75M 0.15% 156
2013
Q4 		$3.05M Buy
33,681
+27,295
+427% +$2.36M 0.08% 240
2013
Q3 		$509K Buy
6,386
+721
+13% +$56.8K 0.01% 402
2013
Q2 		$412K Buy
+5,665
New +$424K 0.01% 472

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Oakbrook Investments's ZBH Position: Q1 2020 in Review

Oakbrook Investments sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 12,116 shares — an estimated $1.76M sold.

Oakbrook Investments first reported a position in ZBH in Q2 2013 and held it in 24 quarters. The position peaked at $5.74M in Q2 2014. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Oakbrook Investments reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 12,116 Zimmer Biomet shares in Q1 2020, an estimated $1.76M.
  • Oakbrook Investments first reported a position in Zimmer Biomet in Q2 2013 and held it in 24 quarters.
  • Oakbrook Investments's Zimmer Biomet position peaked at $5.74M in Q2 2014.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.